Other
Journal
About P&T Journal
Contacts:Editor:
ssherritze@medimedia.com
Advertising:
mliberti@medimedia.com
Circulation:
lgardineer@medimedia.com
Production:
wpeart@medimedia.com
Rate Card
Production Specifications
Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints
Recent Issues
May 2005
Features
Health Care and Law
Support Grows for a Third Class of "Behind-the-Counter” Drugs
Some think that it might be time to add a new class of drugs to the existing categories.
Robert I. Field, JD, MPH, PhD
Risk of Heart Failure with the Use of Thiazolidinediones within a Medicaid Population
Analyzing patients’ prescription and medical claims from a managed care organization, the authors evaluate the risk of heart failure after TZD therapy.
Fadia T. Shaya, PhD, MPH, James Y. Shin, PharmD, C. Daniel Mullins, PhD, Antoine C. El Khoury, PhD, and Howard Garber, MD, MPH
Drug Class Review
Proton Pump Inhibitors in the Management of Patients with Acid-Peptic Disorders: A Managed Care Perspective
Drs. McCarthy and Caspi describe the benefits and risks of intravenous and oral PPIs and the considerations regarding their inclusion on formularies.
Denis M. McCarthy, MD, PhD, MSc, and Alan Caspi, PhD, PharmD, MBA
Case Study
Using Technology to Expand Services: An Application of Satellite Distribution in the Pharmaceutical Market
The authors describe the use of telemedicine and telepharmacy to provide drug delivery to low-income, underserved segments of the population.
LoriAnn Collins, RPh, MBA, Charles J. Quigley, Jr., PhD, and Frank G. Bingham, Jr., EdD
Consensus Panel Recommendations for the Assessment and Management of Breakthrough Pain Part 1 Assessment
The authors illustrate their discussion of cancer-related and non–cancer-related pain in a pertinent case study with an emphasis on pharmacological management.
Daniel Bennett, MD, Allen W. Burton, MD, Scott Fishman, MD,
Barry Fortner, PhD, Bill McCarberg, MD, Chris Miaskowski, PhD, RN,
David B. Nash, MD, MBA, Marco Pappagallo, MD, Richard Payne, MD, James Ray, PharmD, Eugene R. Viscusi, MD, and Winston Wong, PharmD
Departments
Editorial
Relationship Guidance
David Nash, MD, MBA, summarizes one institution’s guidelines for relationships between employees in academic medicine and pharmaceutical sales representatives.
David Nash, MD, MBA
Medication Errors
Errors in the Making: Nearly Unreadable Labeling of Plastic Ampules for Nebulizing Agents
Matthew Grissinger, RPh, FASCP, discusses the increased risk of errors resulting from poorly labeled plastic ampules for nebulizing agents.
Matthew Grissinger, RPh, FASCP
Prescription: Washington
Medical-Error Reporting Bill Starts Up the Mountain . . . Again
Stephen Barlas discusses the Safety and Quality Improvement Act of 2005, which is intended to help decrease medical errors.
Stephen Barlas
New Drugs/Drug News/New Medical Devices
P&T presents the latest information about FDA approvals, drug indications, industry updates, and new devices.
Drug Forecast
Truvada™: A New Combination Therapy to Increase Compliance and Decrease Pill Burden in HIV-Infected Patients
The authors review the benefits of increased compliance and decreased pill burden with Truvada™ for treating HIV infection.
Evans Branch III, PharmD, Marlon Honeywell, PharmD, Wayne Simon, PharmD, Anishka Richardson, PharmD, and Muideen Adigun, PharmD Candidate
